Trending News

Changes to Civil Rights Enforcement: New Executive Order Eliminates Disparate-Impact Liability in Federal Regulations

How Are Family Offices Building Smarter Wealth? Structural Alpha (11 Examples)

DOJ Rule Restricting Sensitive Data Transfers Takes Effect

The Trump Administration’s Diversity, Equity, and Inclusion (DEI) Executive Orders: A Brief Primer

Trump Administration Announces "Reciprocal" Tariffs

What Every Multinational Company Should Know About … The Global and Reciprocal Tariffs Announcement

Blockading the Ports: U.S. Imposes 10% Global Tariff; Higher Reciprocal Tariff Rates by Country

Fifth Circuit Court of Appeals Negates Ruling on Federal Contractor Minimum Wage

New Executive Order Rescinds the $17.75 Per Hour Federal Contractor Minimum Wage

Medicare Telehealth Gets Another Temporary Lifeline – Will Congress Make it Permanent?

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

Revolo to Present at the 2025 AAAAI / WAO Joint Congress
Posted On Monday, February 10, 2025
Cogent Biosciences Announces Bezuclastinib Poster in NonAdvanced Systemic Mastocytosis (NonAdvSM) at the 2025 AAAAI Annual Meeting
Posted On Monday, February 10, 2025
Capricor Therapeutics to Participate in Upcoming Investor Conferences
Posted On Monday, February 10, 2025
Palisade Bio Presents Positive Preclinical Data of PALI-2108 for the Treatment of Ulcerative Colitis
Posted On Monday, February 10, 2025
BioCryst to Present New ORLADEYO® (berotralstat) Results from APeX-P Pediatric Trial at 2025 American Academy of Allergy, Asthma & Immunology / World Allergy Organization Joint Congress
Posted On Monday, February 10, 2025
Biodexa Receives US FDA Fast Track Designation for eRapa in Familial Adenomatous Polyposis
Posted On Monday, February 10, 2025
Achieve Life Sciences Announces Positive Outcome of Second Data Safety Monitoring Committee Review for the ORCA-OL Clinical Trial
Posted On Monday, February 10, 2025
Oncocyte Prices $29.1 Million Equity Offering
Posted On Monday, February 10, 2025
Intelligent Bio Solutions Releases Shareholder Letter Detailing 2024 Growth and 2025 U.S. Expansion Strategy
Posted On Monday, February 10, 2025
Avid Bioservices Launches New Company Website Designed to Boost Company Brand Awareness and Enhance the Visitor Experience
Posted On Monday, February 10, 2025
IMUNON Appoints Douglas V. Faller, M.D., Ph.D., as Chief Medical Officer
Posted On Monday, February 10, 2025
Ashvattha Presents Positive Phase 2 Data for Subcutaneous Migaldendranib at Angiogenesis 2025 Conference
Posted On Monday, February 10, 2025
Grace Therapeutics Announces Results From Pivotal Phase 3 STRIVE-ON Safety Trial of GTx-104 in aSAH
Posted On Monday, February 10, 2025
Qu Biologics’ Immunomodulator Clears Senescence
Posted On Monday, February 10, 2025
Tempest Granted Fast Track Designation from the U.S. Food and Drug Administration for Amezalpat to Treat Patients with Hepatocellular Carcinoma
Posted On Monday, February 10, 2025
Jasper Therapeutics Announces Briquilimab Presentations at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting
Posted On Monday, February 10, 2025
Nutriband Receives Notice Of Allowance For New U.S. Patent Covering Its Transdermal Abuse Deterrent Technology Aversa™
Posted On Friday, February 07, 2025
Alumis and ACELYRIN to Merge Creating a Late-Stage Clinical Biopharma Company Dedicated to Innovating, Developing and Commercializing Transformative Therapies for Immune-mediated Diseases
Posted On Thursday, February 06, 2025
PharmAla Signs Advisory Agreement with Mr. Matthew Azrieli
Posted On Thursday, February 06, 2025
North Texas Took Center Stage at Advanced Therapies Week 2025, Highlighting Innovation and Collaboration in Life Sciences
Posted On Thursday, February 06, 2025
Rakovina Therapeutics Announces Additional Synthesized Compounds in its AI-Driven Cancer Drug Discovery Program
Posted On Thursday, February 06, 2025
Fluorescent Tracers Market to Reach US$ 6.15 Billion by 2035, Expanding at 7.2% CAGR | Fact.MR Report
Posted On Thursday, February 06, 2025
Lipella Pharmaceuticals Granted FDA Approval for Expanded Access Program for LP-310 in Oral Lichen Planus
Posted On Thursday, February 06, 2025
Cytokinetics to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
Posted On Wednesday, February 05, 2025
e-therapeutics to Present Preclinical Data on ETX-148 at EAHAD 2025
Posted On Wednesday, February 05, 2025

Print